EPAS1 and colorectal carcinoma: Ninety percent (n = 47/52) of CRC patients having amplified EPAS1 copy number exhibited higher EPAS1 mRNA level, whereas lower EPAS1 mRNA expression was only found in 53% (n = 16/30) CRC patients with lower EPAS1 copy number (Figure 4A).